T型钙通道调控髓母细胞瘤并可作为治疗靶点
本研究通过公共RNA测序数据、细胞实验、蛋白组学及原位异种移植模型,探讨T型钙通道在髓母细胞瘤中的作用及靶向治疗潜力。T型钙通道在超过30%的髓母细胞瘤中表达上调,高表达与预后较差相关;米贝拉地尔或siRNA沉默可抑制肿瘤细胞生长、活力和侵袭,口服米贝拉地尔抑制异种移植瘤生长并延长动物生存。
要点
- T型钙通道在超过30%的髓母细胞瘤中表达上调,高表达与预后较差相关。
- 米贝拉地尔或siRNA沉默T型钙通道可抑制髓母细胞瘤细胞生长、活力和侵袭。
- 口服米贝拉地尔抑制髓母细胞瘤异种移植瘤生长并延长动物生存。
核心结论
- 本研究首次对髓母细胞瘤中的T型钙通道进行综合多组学表征,并提供将米贝拉地尔重新用于治疗这些相对常见儿童脑肿瘤的临床前数据。
研究设计与样本
- 研究评估公共批量与单细胞RNA-seq数据中T型钙通道表达,用细胞计数、alamar blue、台盼蓝和transwell实验评估米贝拉地尔对细胞生长、死亡和侵袭的影响,用反向蛋白阵列(RPPA)进行蛋白组学药物靶点与信号通路映射,用高维加权基因共表达网络分析(hdWGCNA)生成单细胞RNA-seq共表达模块,并用原位异种移植模型进行米贝拉地尔治疗研究。
主要发现
- T型钙通道在超过30%的髓母细胞瘤肿瘤中表达上调,高表达患者与更差预后相关。
- T型钙通道在批量RNA-seq和单细胞RNA-seq水平上在所有髓母细胞瘤亚组中表达各异。
- 米贝拉地尔处理或siRNA介导的T型钙通道沉默抑制肿瘤细胞生长、活力和侵袭。
- 基于RPPA的蛋白/磷酸蛋白信号通路激活映射和单细胞hdWGCNA识别出T型钙通道抑制后改变的癌症信号通路。
- 口服给予米贝拉地尔抑制髓母细胞瘤异种移植瘤生长并延长动物生存。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The goal of this study was to investigate the role and therapeutic targeting of T-type calcium channels in medulloblastoma, a common and deadly pediatric brain tumor that arises in the cerebellum. METHODS: T-type calcium channel expression was assessed in publicly available bulk and single cell RNA-seq datasets. The effects of T-type calcium channel blocker mibefradil on cell growth, death and invasion were assessed with cell counting, alamar blue, trypan blue and transwell assays. Proteomic-based drug target and signaling pathway mapping was performed with Reverse Phase Protein Arrays (RPPA). Co-expression modules of single cell RNA-seq data were generated using high dimensional weighted gene co-expression network analysis (hdWGCNA). Orthotopic xenografts were used for therapeutic studies with the T-Type calcium channel blocker mibefradil. RESULTS: T-type calcium channels were upregulated in more than 30% of medulloblastoma tumors and patients with high expression associated with a worse prognosis. T-type calcium channels had variable expression across all the subgroups of medulloblastoma at the bulk RNA-seq and single-cell RNA-seq level. Mibefradil treatment or siRNA mediated silencing of T-type calcium channels inhibited tumor cell growth, viability and invasion. RPPA-based protein/phosphoprotein signal pathway activation mapping of T-type calcium channel inhibition and single cell hdWGCNA identified altered cancer signaling pathways. Oral administration of mibefradil inhibited medulloblastoma xenograft growth and prolonged animal survival. CONCLUSION: Our results represent a first comprehensive multi-omic characterization of T-type calcium channels in medulloblastoma and provide preclinical data for repurposing mibefradil as a treatment strategy for these relatively common pediatric brain tumors.
引用
- Dube CJ, Lai M, Zhang Y, et al. T-type calcium channels regulate medulloblastoma and can be targeted for therapy. J Neurooncol. 2025. PMID: 39961940. doi:10.1007/s11060-025-04967-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。